Found 28 matching trials
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer
PHASE2Research purposes: the research design in the late more than 2 lines TNBC p...
Location
Tianjin Cancer Hospital Airport Hospital
Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer
PHASE2This is an open-label, non-randomized, single-arm phase Ⅱ study aiming to e...
Location
The First Affiliated Hospital of Nanjing Medical University
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
PHASE2Soft tissue sarcoma (STS) is a relatively rare type of malignant tumor with...
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
PHASE1The purpose of this study is to explore the efficacy and safety of toripali...
Location
Hubei Cancer Hospital
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC
PHASE2Our aim in this study was to evaluate the efficacy and safety of etoposide ...
Location
Enze Hospital, affiliated Taizhou Hospital of Wenzhou Medical University
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer
PHASE2This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
PHASE2This study aims to evaluate the efficacy and safety of toripalimab and anlo...
Location
Multiple Locations
Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.
PHASE1To explore and evaluate the dose-limiting toxicity (DLT) profile of the fix...
Location
Multiple Locations
Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma
PHASE1The purpose of this study is to evaluate the efficacy and safety of recombi...
Location
Air Force Military Medical University/ Fourth Military Medical University
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)
PHASE2This study is designed to evaluate the efficacy and safety of the combinati...
Location
Department of Medical Oncology, Shanghai Changzheng Hospital